Diabetes is characterized by complex alterations in lipid metabolism, including increased LDL receptor activity and enhanced clearance of circulating LDL particles in some individuals receiving intensive glycemic control or combination therapy with lipid-lowering agents. This evidence concerns the gene LDLR and diabetes mellitus.